SEC Form 4 · accession 0000899243-16-022514
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Ernest Mario
Director · 10% Owner
Period of report
Jun 8, 2016
Accepted (ET)
Jun 10, 2016 · 7:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy)F1 | $1.20 | Jun 8, 2016 | A | 27,083 | A | — | Jun 8, 2026 | Common Stock | 27,083 | 27,083 | D |
Explanation of responses
- F1The vesting schedule for the option is as follows: 100% of the shares subject to the option shall vest on the earlier of the 12 month anniversary of the date of grant or the day before the next annual stockholder meeting.